| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.15▼ | 4.20▼ | 4.23▼ | 4.28▼ | 4.50▼ |
| MA10 | 4.15▼ | 4.25▼ | 4.23▼ | 4.34▼ | 4.29▼ |
| MA20 | 4.20▼ | 4.25▼ | 4.29▼ | 4.53▼ | 4.07▲ |
| MA50 | 4.25▼ | 4.29▼ | 4.30▼ | 4.21▼ | 6.16▼ |
| MA100 | 4.26▼ | 4.30▼ | 4.45▼ | 4.06▲ | N/A |
| MA200 | 4.30▼ | 4.47▼ | 4.51▼ | 5.32▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.011▼ | -0.013▼ | -0.077▼ | 0.245▲ |
| RSI | 38.280▼ | 35.715▼ | 37.511▼ | 40.208▼ | 44.922▼ |
| STOCH | 29.161 | 41.807 | 44.721 | 23.325 | 73.247 |
| WILL %R | -87.500▼ | -90.909▼ | -94.286▼ | -97.103▼ | -41.798 |
| CCI | -75.347 | -101.573▼ | -139.213▼ | -96.988 | 34.999 |
|
Wednesday, September 17, 2025 01:53 AM
Stifel Virtual Immunology and Inflammation Forum September 16, 2025 12:30 PM EDTCompany ParticipantsMartin Babler - President, ...
|
|
Thursday, August 28, 2025 05:00 PM
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with ...
|
|
Wednesday, August 13, 2025 01:27 PM
GAAP revenue was $2.7 million for Q2 2025, missing analyst estimates by 20.6%. Operating expenses surged, driven by costs tied to the ACELYRIN merger and clinical trial acceleration. The merger ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/09/25 | 4.13 | 4.34 | 4.12 | 4.14 | 242,498 |
| 16/09/25 | 4.37 | 4.47 | 4.145 | 4.16 | 457,466 |
| 15/09/25 | 4.36 | 4.42 | 4.23 | 4.38 | 357,334 |
| 12/09/25 | 4.37 | 4.4091 | 4.19 | 4.37 | 448,703 |
| 11/09/25 | 4.30 | 4.42 | 4.24 | 4.36 | 343,575 |
| 10/09/25 | 4.27 | 4.465 | 4.24 | 4.30 | 428,798 |
| 09/09/25 | 4.27 | 4.32 | 4.115 | 4.27 | 402,297 |
| 08/09/25 | 4.50 | 4.515 | 4.28 | 4.32 | 414,924 |
| 05/09/25 | 4.56 | 4.665 | 4.41 | 4.51 | 498,117 |
| 04/09/25 | 4.76 | 4.76 | 4.32 | 4.60 | 573,623 |
|
|
||||
|
|
||||
|
|